Search

Search Constraints

You searched for: Author/Creator Motoshima, Hiroyuki

Search Results

1. A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study). Issue 5 (19th March 2016)

2. Activation of heat shock response improves biomarkers of NAFLD in patients with metabolic diseases. Issue 5 (19th May 2021)

3. Activation of heat shock response improves glucose metabolism and inflammation in obese subjects with type 2 diabetes. (October 2016)

4. An observational study of diabetes outpatients switching from glargine or detemir to degludec. (October 2016)

5. Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma. (1st May 2016)

6. Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination. Issue 3 (22nd October 2013)

7. Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoE-deficient mice. (October 2016)

8. Impact of tissue macrophage proliferation on peripheral and systemic insulin resistance in obese mice with diabetes. Issue 1 (21st October 2020)

9. Impact of tissue macrophage proliferation on peripheral and systemic insulin resistance in obese mice with diabetes. Issue 1 (21st October 2020)

10. Impact of tissue macrophage proliferation on peripheral and systemic insulin resistance in obese mice with diabetes. Issue 1 (21st October 2020)